Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

William O’Neill, M.D., Henry Ford Hospital, speaking at the announcement of the creation of the Cardiogenic Shock Initiative in 2016. O'Neill asked the same partner hospitals in the Detroit area to pool resources to create a COVID-19 study group to help speed the gathering of data in COVID-19 drug trials.

News | Coronavirus (COVID-19)

Cardiologists Head COVID-19 Trial Collaboration in Detroit Area Hospitals

March 31, 2020 — Four metropolitan Detroit hospital systems and a leading research university announced a collaboration ...

March 31, 2020

The Edwards Lifesciences Cardioband for tricuspid valve regurgitation. #COVID19 #coronavirus

News | Heart Valve Technology

Edwards Pauses Enrollments In Pivotal Mitral, Tricuspid Trials in Response to Hospitals' COVID-19 Focus

March 30, 2020 — Edwards Lifesciences Corp. announced it is temporarily pausing new enrollments in its active pivotal ...

March 30, 2020

AHA, ACC, HRS, SCAI and other medical societies call for federal government to do what is needed to get medical supplies to front-line clinicians fighting COVID-19. #COVID19 #SARScov2 #Coronavirus

News | Coronavirus (COVID-19)

Healthcare Societies Issue Urgent Call for Federal Action to Address COVID-19 Medical Equipment Shortages

March 30, 2020 — A group of 13 U.S. medical societies sent an open letter to Congress appealing to them to do what is ...

March 30, 2020

Conclusions from the TAVR vs surgery trial for aortic valve replacement in the U.K. presented by William D. Toff, M.D. at ACC 20. #ACC20 #ACC2020 #TAVR #TAVR

News | Heart Valve Technology

TAVR Non-Inferior to Surgery in U.K. Review of Surgery vs. TAVR

March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR) did ...

March 30, 2020

PARTNER 3 trial shows positive results for Sapien 3 in low-risk surgical patients. #ACC20 #ACC2020 #Sapien3 #TAVR

Feature | Heart Valve Technology

TAVR Equivalent to Surgery at Two Years in Low-Risk Patients

March 30, 2020 — Low-risk patients undergoing transcatheter aortic valve repair (TAVR) at two years did just as well ...

March 30, 2020

News | Heart Valve Technology

U.S. TAVR Outcomes Need Improvement Based on TVT Registry Analysis

March 29, 2020 — Worse than expected outcomes were found for survival and quality of life among patients undergoing ...

March 29, 2020

$Patients with worsening heart failure and reduced ejection fraction who received the investigational drug vericiguat had a significantly lower rate of cardiovascular death or heart failure hospitalization compared with those receiving a placebo, based on research presented at the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) #ACC20/#WCCardio$

News | Heart Failure

Vericiguat Improves Outcomes in Patients with Worsening Heart Failure

March 29, 2020 — Patients with worsening heart failure and reduced ejection fraction who received the investigational ...

March 29, 2020

Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days, according to new data presented at the American College of Cardiology (ACC) 2020 Scientific Session. #ACC20 #ACC2020

Feature | Heart Valve Technology | Dave Fornell, Editor

TAVR Shows Favorable Safety in Patients with Bicuspid Valve

March 29, 2020 — Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve ...

March 29, 2020

POPULAR TAVR trial Shows Oral Anticoagulants Alone in atrial fibrillation (AF) Patients Reduces Bleeding Post TAVR, transcatheter aortic valve replacement. #ACC20 #ACC2020

News | Atrial Fibrillation

March 29, 2020 — Patients with atrial fibrillation (AF) who took oral anticoagulants alone after undergoing ...

March 29, 2020

News | Heart Failure

Dapagliflozin Reduces Heart Failure Worsening and Death in DAPA-HF Sub-analysis

March 28, 2020 — New data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse ...

March 28, 2020

News | Coronavirus (COVID-19)

ESC and Other Societies Creates a COVID-19 Resource Pages for Cardiology

March 27, 2020 — The European Society of Cardiology (ESC) has created a novel coronavirus resource page with information ...

March 27, 2020

Videos | Coronavirus (COVID-19)

VIDEO: Telemedicine in Cardiology and Medical Imaging During COVID-19

Regina Druz, M.D., FASNC, a member of the American Society of Nuclear Cardiology (ASNC) Board of Directors, chairwomen ...

March 26, 2020

The heart team at St. James University Hospital Dublin was the first to perform a human implant of the CroiValve Duo Tricuspid Coaptation Valve technology for tricuspid repair.

News | Heart Valve Technology

First Human Use of Transcatheter Duo Tricuspid Valve Announced in Ireland

March 25, 2020 — CroiValve announced the successful first human use of its Duo Tricuspid Coaptation Valve ...

March 25, 2020

News | Coronavirus (COVID-19) | Dave Fornell, Editor

FDA Takes Action to Increase Supply of Personal Protective Equipment Amid COVID-19 Shortages

March 25, 2020 — The U.S. Food and Drug Administration (FDA) said it is taking action to increase U.S. supplies of ...

March 25, 2020

Videos | Structural Heart Occluders

VIDEO: Transcatheter PFO Closure to Prevent Stroke and Migraines

Interview with Carey Kimmelstiel, M.D., FACP, FACC, director, cardiac catheterization laboratory, director ...

March 24, 2020